overview corporate governance strategy history people contact news register careers
manufacturing quality regulatory
product licensing opportunities ip licensing opportunities
products in development
financial reports financial calendar corporate advisers share information admission documents shareholder circulars
financial regulatory industry

MANUFACTURING

GeneMedix’s Head Office, main manufacturing and development facility is located within a 1950m building on the Sragh Industrial Estate in Tullamore, County Offaly, Ireland – about 1.5 hours’ drive from Dublin International Airport.

state-of-the-art equipment at our Tullamore facility

The facility has obtained a Good Manufacturing Practice (GMP) licence from the Irish Medicine Board and is currently undergoing expansion to gear up for commercial manufacture of its main product fitted erythropoietin [EPO]. There is an intention to introduce new projects to the facility over the coming period, and potentially to find other sites of manufacture in the locality.

Paul Edwards, former GeneMedix CEO, at the official opening of the Tullamore facilityLed in Ireland by the General Manger, Conor O’Dea, a highly skilled and experienced workforce has been established and rigorous quality systems instigated to ensure that the quality of product will meet the highest standards of cGMP.

members of the Tullamore teamThe Ireland manufacturing facility was officially opened on 24 June 2002 by Brian Cowen TD, the Irish Minister for Foreign Affairs, in the company of several VIPs from the Irish Government and the local community.

GeneMedix Ireland currently employs 32 people, who are manufacturing EPO, used in chronic renal failure and oncology. GeneMedix has registered the tradename Epostim® for use in relation to EPO. The Company is currently in its clinical programme and running validation programmes for its regulatory submissions.